WALL, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that North Central College in Naperville, IL, has selected its PortalGuard IDaaS platform to secure access to critical enterprise applications, enhance its online user experience, and reduce IT resource-related expenses. BIO-key continues to expand its national footprint in higher education with over 200 higher education institutions, including 30 IDaaS customers across 12 states, supporting over 2.5 million students, faculty, staff, administration, and alumni with cloud-based solutions.
PortalGuard IDaaS will significantly improve user access by providing secure multi-factor authentication (MFA) and single sign-on (SSO) to campus-wide applications, including Microsoft Office 365, Blackboard, and Ellucian Colleague, among others, while replacing expensive competitive solutions that are challenging to manage and support. By leveraging PortalGuard’s robust self-service password reset capabilities, North Central College can solve a significant IT pain point and essentially eliminate related help desk costs providing an immediate return on investment. Deployments of PortalGuard IDaaS continue to gain momentum across multiple industries, including education, healthcare, finance, and government, by cost-effectively addressing today’s cyber threats and enabling the migration of on-premise IAM solutions to the cloud.
“Higher Education has become an attractive target for cyberattacks, so institutions are seeking highly secure, scalable, and redundant IAM solutions to safeguard both student and institutional data and resources,” said Mark Cochran, President of BIO-key – PortalGuard. “The BIO-key security team, with our comprehensive suite of IAM solutions, is uniquely positioned to assist higher-ed institutions with enhancing their information security plans and effectively addressing the challenging risks to institutional security and privacy.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key:
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
BIO-key Media Contact:
Erin Knapp
Matter Communications
BIO-key@matternow.com
914-260-3158
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
